<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
 xmlns:blogChannel="http://backend.userland.com/blogChannelModule"
>

<channel>
<title>Infections in Medicine</title>
<link>http://infections.consultantlive.com</link>
<description>Infections in Medicine
</description>
<language>en</language>
<copyright>Copyright 2009, CMPMedica US</copyright>
<pubDate>Thu, 17 May 2012 01:30:01 GMT</pubDate>
<lastBuildDate>Thu, 17 May 2012 01:30:01 GMT</lastBuildDate>
<docs>http://blogs.law.harvard.edu/tech/rss</docs>

<item>
<title>Invasive Fungal Sinusitis</title>
<link>http://infections.consultantlive.com/display/article/1145625/1526057?CID=rss</link>
<description>With advances in chemotherapy, transplantation, and the treatment of diabetes and HIV infection, fungal sinusitis has become increasingly recognized in patients in these at-risk groups.</description>
<pubDate>Fri, 19 Feb 2010 12:00:00 GMT</pubDate>
</item>
<item>
<title>H1N1 Influenza Virus of Swine Origin: Emergence of a New Pandemic Strain</title>
<link>http://infections.consultantlive.com/display/article/1145625/1481909?CID=rss</link>
<description>A novel H1N1 influenza virus has emerged from swine and is causing a worldwide pandemic. Children and young adults have been most affected, in terms of both numbers of cases and severity of disease. Perhaps the most striking feature of the pandemic so far is that fewer than half of those hospitalized or killed by this virus have had identifiable prior medical conditions or risk factors.</description>
<pubDate>Thu, 29 Oct 2009 12:00:00 GMT</pubDate>
</item>
<item>
<title>Can We Beat MRSA by Shedding Light on It?</title>
<link>http://infections.consultantlive.com/display/article/1145625/1474817?CID=rss</link>
<description>THAT BLUE LIGHT KILLS methicillin-resistant Staphylococcus aureus (MRSA) was demonstrated in the article &#x201C;Visible 405 nm SLD Light Photo-Destroys Methicillin-Resistant Staphylococcus aureus (MRSA) In Vitro,&#x201D; in the December 2008 issue of Lasers in Surgery and Medicine. Concerns about the clinical safety of the wavelength used (405 nm, spectral width 390 to 420 nm), which contains traces of ultraviolet light, led Chukuka Enwemeka, PhD, and colleagues from the School of Health Professions, Behavioral and Life Sciences at New York Institute of Technology in Old Westbury, to recapitulate the experiment using a wavelength of 470 nm with similar results.</description>
<pubDate>Sun, 13 Sep 2009 12:00:00 GMT</pubDate>
</item>
<item>
<title>Diagnosis of isolated axillary neuropathy in athletes: Case studies</title>
<link>http://infections.consultantlive.com/display/article/1145625/1435040?CID=rss</link>
<description>Isolated axillary neuropathy is a somewhat uncommon diagnosis, but it may not be as rare as might be expected. Given a thorough clinical history, physical examination, and timely studies, the diagnosis needs to be considered in the differential in the proper setting. Sports and other activities in which this injury might occur include overhead sports (eg, volleyball, javelin), racquet sports, gymnastics, rock climbing, workouts that involve shoulder traction (eg, pullups), and contact sports that involve tackling with an extended arm (eg, rugby, American football).</description>
<pubDate>Wed, 5 Aug 2009 12:00:00 GMT</pubDate>
</item>
<item>
<title>Continued Cytological Monitoring for Cervical Cancer Despite Prior Vaccination</title>
<link>http://infections.consultantlive.com/display/article/1145625/1419201?CID=rss</link>
<description>The human papilloma viruses (HPVs) are among the widespread sexually transmitted pathogens infecting women. Like HIV, HPV&#x2013;s</description>
<pubDate>Wed, 3 Jun 2009 12:00:00 GMT</pubDate>
</item>
<item>
<title>siRNA-Laced Intravaginal Gel Wipes Out HSV-2 in Experimental Models</title>
<link>http://infections.consultantlive.com/display/article/1145625/1419171?CID=rss</link>
<description>A TOPICAL TREATMENT THAT KILLS herpes simplex virus type 2 (HSV-2) and that has long staying power may be available in the future. The experimental microbicidal solution, consisting of cholesterol-conjugated small interfering RNA (chol-siRNA), was tested in female mice that were given a lethal dose of the virus. The solution, delivered intravaginally, had a remarkably protective effect.</description>
<pubDate>Wed, 3 Jun 2009 12:00:00 GMT</pubDate>
</item>
<item>
<title>Disseminated Echinococcosis Involving the Pulmonary Artery</title>
<link>http://infections.consultantlive.com/display/article/1145625/1419022?CID=rss</link>
<description>Disseminated echinococcal disease can present complex management issues that require a multidisciplinary approach to care. We describe a patient with hydatid disease who had multiple cysts in the liver, lungs, and pulmonary artery that were caused by Echinococcus granulosus infection.</description>
<pubDate>Wed, 3 Jun 2009 12:00:00 GMT</pubDate>
</item>
<item>
<title>Herpes Simplex: Initial and Recurrent Infections</title>
<link>http://infections.consultantlive.com/display/article/1145625/1418984?CID=rss</link>
<description>Herpes simplex virus (HSV) infections are caused by 2 types of HSV: type 1 (HSV-1) and type 2 (HSV-2). Most cases of HSV infection are caused by HSV-2. Most persons with HSV-1 or HSV-2 infection have no or only minimal signs or symptoms. When signs do occur, they usually appear as one or more small blisters or sores on or around the mouth, lips, nose, face, genitals, and buttocks. HSV infections are very contagious and are spread by direct contact with the skin lesions.</description>
<pubDate>Wed, 3 Jun 2009 12:00:00 GMT</pubDate>
</item>
</channel>
</rss>
